Human NCAPD3 ELISA Kit (V2LY-0626-LY4439)

Lu, T., Zhou, X., Yang, J., Cai, Y., Ding, M., Chen, X., ... & Wang, X. (2023). NCAPD3 Prompts Diffuse Large B-Cell Lymphoma Progression through Modulating SIRT1 Expression in H3K9 Monomethylation-Dependent Manner. Blood, 142, 4363.

Jing, Z., Liu, Q., Xie, W., Wei, Y., Liu, J., Zhang, Y., ... & Liu, P. (2022). NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1. Cellular signalling, 92, 110265.

Yin, Y., Liu, Q., Shao, Y., He, X., Zhu, Q., Lu, S., & Liu, P. (2022). Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer. The Prostate, 82(1), 26-40.

Jing, Z., Liu, Q., He, X., Jia, Z., Xu, Z., Yang, B., & Liu, P. (2022). NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer. Journal of Experimental & Clinical Cancer Research, 41(1), 1-18.

Kheirkhah, S., Javanzad, M., Hoseinzadeh, M., Mehrabani, Z. H. A., Mohammadzadeh, N., & Monfaredan, A. (2020). Monitoring prostate cancer (PCa) with appraise the gene expression of PRUNE2, NCAPD3 and ASPA and their connection with age, family history and tumor stage. Gene Reports, 21, 100840.

Yang, J., Li, Y., Zhang, Y., Zhou, X., Zhao, Y., Han, Y., ... & Wang, X. (2019). NCAPD3 Regulates Tumor Growth and Predicts Prognosis in Diffuse Large B-Cell Lymphoma. Blood, 134, 5045.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols